P83. Predictive modeling for pseudarthrosis performance benchmarking in 404 patients with a minimum two-year follow up
Justin K. Scheer, MD1; Ferran Pellise, MD, PhD2; Christopher I. Shaffrey, MD3; Justin S. Smith, MD, PhD4; Eric O. Klineberg, MD5; Shay Bess, MD6; Peter G. Passias, MD7; Themistocles S. Protopsaltis, MD8; Douglas C. Burton, MD9; Virginie Lafage, PhD10; Frank J. Schwab, MD10; Miquel Serra-Burriel, PhD2; Christopher P. Ames, MD1; International Spine Study Group11
1University of California, San Francisco, San Francisco, CA, US; 2Barcelona, Spain; 3University of Virginia, Charlottesville, VA, US; 4UVA Health System, Charlottesville, VA, US; 5UC, Davis School of Medicine, Sacramento, CA, US; 6Denver, CO, US; 7NY Spine Institute, NYU Langone Health, New York, NY, US; 8Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 9University of Kansas Medical Center, Kansas City, KS, US; 10Hospital for Special Surgery, New York, NY, US; 11Brighton, CO, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
P80. The impact of body mass index (BMI) on postoperative outcomes following posterior spinal fusion in neuromuscular scoliosis
Azeem T. Malik, MBBS1; Robert Tamer, MPH2; Elizabeth Yu, MD1; Jeffery Kim, MD1; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Department of Orthopaedics, Columbus, OH, US>
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.